TOMSK, RUSSIA / RankWire.AI / – Russian scientists have investigated a bioactive layer aimed at improving the interaction between titanium orthopedic implants and bone tissue. This material incorporates calcium phosphate derived from hydroxyapatite and includes nitrogen compounds linked to nitric oxide production. Laboratory experiments demonstrated that human mesenchymal stem cells exhibited significantly higher survival rates on coated surfaces compared to uncoated titanium. The researchers analyzed the coating’s structure, chemistry, mechanical attributes, and biological effects. Their peer-reviewed results were published in Applied Surface Science in 2026.
At Tomsk Polytechnic University, scientists developed the experimental coatings via reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen and argon gas ratios during deposition to observe how each mixture influenced the surface properties. The study tested five different conditions, ranging from pure nitrogen to pure argon. They measured coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, they conducted laboratory assessments to evaluate how living human cells responded to the modified titanium surfaces.
The results indicated that the amount of argon affected several physical characteristics of the coatings. Surfaces deposited with pure argon were denser and harder than those created with pure nitrogen. The thickness of the coatings also increased with higher argon proportions. Chemical analyses revealed nitrogen-carbon and nitrogen-oxygen bonds present on the modified surfaces. The team then compared the growth of human mesenchymal stem cells on coated titanium with that on uncoated samples. The biological tests focused on cell viability and markers associated with bone cell development.
Enhanced Cell Viability Observed on Coated Implants
The experiments showed that coated surfaces significantly improved cell survival compared to uncoated titanium, according to the study. After seven days, coatings with higher nitrogen content also led to decreased activity in certain genes linked to early bone-cell differentiation. Despite this, the cells retained their capacity to form bone tissue. These effects were examined under controlled laboratory conditions using human mesenchymal stem cells. It is important to note that the study did not involve testing the coating in patients or assessing clinical performance of medical implants.
The biomedical evaluation was conducted by Immanuel Kant Baltic Federal University and Siberian State Medical University. Researchers from Saint Petersburg State University also contributed to the broader research effort. Funding was provided through Russia’s national science program. The team’s focus was on identifying gas mixtures capable of producing coatings with desirable physical, chemical, and biological qualities. Hydroxyapatite’s calcium phosphate composition makes it suitable for implant coatings due to its similarity to the mineral component of human bone.
Research Still in Preliminary Laboratory Stage
The research team has planned further testing beyond the initial seven-day cell viability evaluation. Future plans include studying stem cell behavior over 10 to 28 days and investigating the rate at which the coatings dissolve. They also aim to measure nitric oxide release into surrounding tissue in living organisms. These aspects were not part of the current published laboratory results. Presently, the focus remains on coated titanium substrates, their physical and chemical properties, and cell responses in vitro, rather than on clinical outcomes in orthopedic patients.
The findings provide comprehensive laboratory data on how different ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. Variations in thickness, density, hardness, chemical bonds, and cellular responses across the tested gas mixtures were documented. The study confirmed that coated samples supported higher stem-cell survival compared to uncoated titanium under laboratory conditions. However, as these results are preclinical, they do not establish safety or effectiveness in humans. Additional biological studies are required to evaluate properties not addressed in this initial research.